Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Christopher Gorski

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of the American Society of Nephrology : JASN|May 23, 2000
Urinary protein binding does not affect response to furosemide in patients with nephrotic syndromeRajiv Agarwal, J Christopher Gorski, Kimberly Sundblad, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2001
Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampinAli Asghar, J Christopher Gorski, Barbara Haehner-Daniels, et al.
Journal of Clinical Pharmacology|May 22, 2010
Effects of commonly administered agents and genetics on nebivolol pharmacokinetics: drug-drug interaction studiesCharles Lindamood, Stephan Ortiz, Andrew Shaw, et al.
British Journal of Clinical Pharmacology|April 20, 2004
Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal studyRobert J MacFadyen, J Christopher Gorski, D Craig Brater, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 18, 2006
Insulin sensitivity is preserved despite disrupted endothelial functionSudha S Shankar, Robert V Considine, J Christopher Gorski, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 8, 2009
Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metaboliteXin Zhang, Sara K Quinney, J Christopher Gorski, et al.
Hepatology (Baltimore, Md.)|April 21, 2005
Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholicsSuthat Liangpunsakul, Dhanashri Kolwankar, Amar Pinto, et al.
American Heart Journal|November 18, 2005
Indinavir impairs endothelial function in healthy HIV-negative menSudha S Shankar, Michael P Dubé, J Christopher Gorski, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 4, 2009
Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycinSara K Quinney, Xin Zhang, Aroonrut Lucksiri, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 12, 2005
Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearanceSilvana Borges, Lang Li, Mitchell A Hamman, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of the American Society of Nephrology : JASN|May 23, 2000
Urinary protein binding does not affect response to furosemide in patients with nephrotic syndromeRajiv Agarwal, J Christopher Gorski, Kimberly Sundblad, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2001
Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampinAli Asghar, J Christopher Gorski, Barbara Haehner-Daniels, et al.
Journal of Clinical Pharmacology|May 22, 2010
Effects of commonly administered agents and genetics on nebivolol pharmacokinetics: drug-drug interaction studiesCharles Lindamood, Stephan Ortiz, Andrew Shaw, et al.
British Journal of Clinical Pharmacology|April 20, 2004
Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal studyRobert J MacFadyen, J Christopher Gorski, D Craig Brater, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 18, 2006
Insulin sensitivity is preserved despite disrupted endothelial functionSudha S Shankar, Robert V Considine, J Christopher Gorski, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 8, 2009
Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metaboliteXin Zhang, Sara K Quinney, J Christopher Gorski, et al.
Hepatology (Baltimore, Md.)|April 21, 2005
Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholicsSuthat Liangpunsakul, Dhanashri Kolwankar, Amar Pinto, et al.
American Heart Journal|November 18, 2005
Indinavir impairs endothelial function in healthy HIV-negative menSudha S Shankar, Michael P Dubé, J Christopher Gorski, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 4, 2009
Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycinSara K Quinney, Xin Zhang, Aroonrut Lucksiri, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 12, 2005
Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearanceSilvana Borges, Lang Li, Mitchell A Hamman, et al.
Pageof 3